ACHC vs SGRY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACHC Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Healthcare Company, Inc. (ACHC) driven by superior Valuation, Options & Structure while SGRY counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, ACHC trades at 17.0x Forward P/E with 9.8% operating margin (+5.1% YoY revenue) versus SGRY at N/M Forward P/E and 13.2% operating margin (-0.8% YoY). In options structure, ACHC sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro) against SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ACHC Revenue | SGRY Revenue | ACHC Op. Margin | SGRY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.90B | $1.77B | 31.2% | 4.4% | ACHC |
| FY2019 | $2.01B | $1.83B | 29.2% | 12.9% | ACHC |
| FY2020 | $2.09B | $1.86B | -32.2% | 9.8% | SGRY |
| FY2021 | $2.31B | $2.23B | 8.2% | 13.6% | SGRY |
| FY2022 | $2.61B | $2.54B | 10.5% | 13.6% | SGRY |
| FY2023 | $2.93B | $2.74B | -0.7% | 12.0% | SGRY |
| FY2024 | $3.15B | $3.11B | 8.1% | 11.2% | SGRY |
| FY2025 | $3.31B | $3.31B | -33.3% | 11.8% | SGRY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACHC | SGRY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2B | $3.5B | Larger Scale | SGRY |
| Trailing P/E Ratio Valuation | 16.9x | N/M | Lower Multiple | ACHC |
| Forward P/E Ratio Valuation | 17.0x | N/M | Lower Multiple | ACHC |
| Revenue Growth (YoY) Growth | +5.1% | -0.8% | Higher Growth | ACHC |
| Operating Margin (TTM) Profitability | 9.8% | 13.2% | Higher Margin | SGRY |
| Net Profit Margin Profitability | -33.1% | -2.6% | Higher Margin | SGRY |
| Return on Equity (ROE) Capital Efficiency | -40.5% | 2.1% | Higher ROE | SGRY |
| 52-Week Range Position Momentum | 82% ($11โ$40) | 97% ($11โ$27) | Stronger Trend | SGRY |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 61% Vol | 0.87ฮฒ ยท 166% Vol | Lower Realized Risk | ACHC |
| Unified Institutional Score Composite Signal | 33.1 / 100 (SELL) | 29.6 / 100 (SELL) | Higher Composite | ACHC |